ID

29251

Description

Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01006291

Lien

https://clinicaltrials.gov/show/NCT01006291

Mots-clés

Versions (1)
  1. 12/03/2018 12/03/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

12 mars 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes NCT01006291

Anglais

Eligibility Diabetes NCT01006291

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01006291
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus (diagnosed clinically) for at least 6 months
Description

Non-Insulin-Dependent Diabetes Mellitus Disease length

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0872146
current treatment: oral anti-diabetic drug(s) (oad(s)) alone, basal insulin alone or the combination of oad(s) and basal insulin. allowed oads are: metformin, insulin secretagogues (sulphonylureas (su) or glinides), pioglitazone with unchanged dosing for at least 3 months prior to visit 1
Description

Antidiabetics Oral Dose unchanged | Basal insulin | Combined Modality Therapy | Metformin | Pills Insulin Releasing | Sulfonylurea | Glinides | pioglitazone

Type de données

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0178602
UMLS CUI [1,4]
C0442739
UMLS CUI [2]
C0650607
UMLS CUI [3]
C0009429
UMLS CUI [4]
C0025598
UMLS CUI [5,1]
C0994475
UMLS CUI [5,2]
C0021641
UMLS CUI [5,3]
C1283071
UMLS CUI [6]
C0038766
UMLS CUI [7]
C3537178
UMLS CUI [8]
C0071097
hba1c: oads only users 7.0-11.0 % (both inclusive), basal insulin with/without oads users 7.0-10.0% (both inclusive) by central laboratory analysis
Description

Glucohemoglobin measurement | Antidiabetics Oral | Basal insulin

Type de données

boolean

Alias
UMLS CUI [1]
C0202054
UMLS CUI [2,1]
C0935929
UMLS CUI [2,2]
C1527415
UMLS CUI [3]
C0650607
body mass index (bmi) below or equal to 40.0 kg/m^2
Description

Body mass index

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
cancer and medical history of cancer hereof
Description

Malignant Neoplasms

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
use within the last 3 months prior to visit 1 of: glucagon-like peptide-1(glp-1) receptor agonist (exenatide, liraglutide), rosiglitazone, dipeptidyl peptidase iv (dpp-iv) inhibitors, alpha-glucosidase-inhibitors
Description

GLP-1 Receptor Agonist | exenatide | liraglutide | rosiglitazone | Dipeptidyl Peptidase 4 Inhibitors | alpha-Glucosidase Inhibitors

Type de données

boolean

Alias
UMLS CUI [1]
C2917359
UMLS CUI [2]
C0167117
UMLS CUI [3]
C1456408
UMLS CUI [4]
C0289313
UMLS CUI [5]
C2917254
UMLS CUI [6]
C1299007
cardiovascular disease, within the last 6 months prior to visit 1, defined as: stroke; decompensated heart failure new york heart association (nyha) class iii or iv; myocardial infarction; unstable angina pectoris; or coronary arterial bypass graft or angioplasty
Description

Cardiovascular Disease | Cerebrovascular accident | Decompensated cardiac failure New York Heart Association Classification | Myocardial Infarction | Angina, Unstable | Coronary Artery Bypass Surgery | Angioplasty

Type de données

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0038454
UMLS CUI [3,1]
C0581377
UMLS CUI [3,2]
C1275491
UMLS CUI [4]
C0027051
UMLS CUI [5]
C0002965
UMLS CUI [6]
C0010055
UMLS CUI [7]
C0162577
uncontrolled treated/untreated severe hypertension (systolic blood pressure at least 180 millimetre (mm) mercury (hg) and/or diastolic blood pressure at least 100 mmhg)
Description

Severe Hypertension Uncontrolled Treated | Severe Hypertension Uncontrolled untreated | Systolic Pressure | Diastolic blood pressure

Type de données

boolean

Alias
UMLS CUI [1,1]
C4013784
UMLS CUI [1,2]
C0205318
UMLS CUI [1,3]
C1522326
UMLS CUI [2,1]
C4013784
UMLS CUI [2,2]
C0205318
UMLS CUI [2,3]
C0332155
UMLS CUI [3]
C0871470
UMLS CUI [4]
C0428883
pregnancy, breast-feeding, the intention of becoming pregnant or not using adequate contraceptive measures according to local requirements
Description

Pregnancy | Breast Feeding | Pregnancy, Planned | Contraceptive methods Absent

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
UMLS CUI [4,1]
C0700589
UMLS CUI [4,2]
C0332197
cancer and medical history of cancer hereof (except basal cell skin cancer and squamous cell skin cancer)
Description

Malignant Neoplasms | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
Retour au début de la page

Similar models

Eligibility Diabetes NCT01006291

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01006291
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
type 2 diabetes mellitus (diagnosed clinically) for at least 6 months
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Antidiabetics Oral Dose unchanged | Basal insulin | Combined Modality Therapy | Metformin | Pills Insulin Releasing | Sulfonylurea | Glinides | pioglitazone
Item
current treatment: oral anti-diabetic drug(s) (oad(s)) alone, basal insulin alone or the combination of oad(s) and basal insulin. allowed oads are: metformin, insulin secretagogues (sulphonylureas (su) or glinides), pioglitazone with unchanged dosing for at least 3 months prior to visit 1
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0442739 (UMLS CUI [1,4])
C0650607 (UMLS CUI [2])
C0009429 (UMLS CUI [3])
C0025598 (UMLS CUI [4])
C0994475 (UMLS CUI [5,1])
C0021641 (UMLS CUI [5,2])
C1283071 (UMLS CUI [5,3])
C0038766 (UMLS CUI [6])
C3537178 (UMLS CUI [7])
C0071097 (UMLS CUI [8])
Glucohemoglobin measurement | Antidiabetics Oral | Basal insulin
Item
hba1c: oads only users 7.0-11.0 % (both inclusive), basal insulin with/without oads users 7.0-10.0% (both inclusive) by central laboratory analysis
boolean
C0202054 (UMLS CUI [1])
C0935929 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0650607 (UMLS CUI [3])
Body mass index
Item
body mass index (bmi) below or equal to 40.0 kg/m^2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms
Item
cancer and medical history of cancer hereof
boolean
C0006826 (UMLS CUI [1])
GLP-1 Receptor Agonist | exenatide | liraglutide | rosiglitazone | Dipeptidyl Peptidase 4 Inhibitors | alpha-Glucosidase Inhibitors
Item
use within the last 3 months prior to visit 1 of: glucagon-like peptide-1(glp-1) receptor agonist (exenatide, liraglutide), rosiglitazone, dipeptidyl peptidase iv (dpp-iv) inhibitors, alpha-glucosidase-inhibitors
boolean
C2917359 (UMLS CUI [1])
C0167117 (UMLS CUI [2])
C1456408 (UMLS CUI [3])
C0289313 (UMLS CUI [4])
C2917254 (UMLS CUI [5])
C1299007 (UMLS CUI [6])
Cardiovascular Disease | Cerebrovascular accident | Decompensated cardiac failure New York Heart Association Classification | Myocardial Infarction | Angina, Unstable | Coronary Artery Bypass Surgery | Angioplasty
Item
cardiovascular disease, within the last 6 months prior to visit 1, defined as: stroke; decompensated heart failure new york heart association (nyha) class iii or iv; myocardial infarction; unstable angina pectoris; or coronary arterial bypass graft or angioplasty
boolean
C0007222 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0581377 (UMLS CUI [3,1])
C1275491 (UMLS CUI [3,2])
C0027051 (UMLS CUI [4])
C0002965 (UMLS CUI [5])
C0010055 (UMLS CUI [6])
C0162577 (UMLS CUI [7])
Severe Hypertension Uncontrolled Treated | Severe Hypertension Uncontrolled untreated | Systolic Pressure | Diastolic blood pressure
Item
uncontrolled treated/untreated severe hypertension (systolic blood pressure at least 180 millimetre (mm) mercury (hg) and/or diastolic blood pressure at least 100 mmhg)
boolean
C4013784 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C1522326 (UMLS CUI [1,3])
C4013784 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0332155 (UMLS CUI [2,3])
C0871470 (UMLS CUI [3])
C0428883 (UMLS CUI [4])
Pregnancy | Breast Feeding | Pregnancy, Planned | Contraceptive methods Absent
Item
pregnancy, breast-feeding, the intention of becoming pregnant or not using adequate contraceptive measures according to local requirements
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0700589 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Malignant Neoplasms | Exception Basal cell carcinoma | Exception Squamous cell carcinoma of skin
Item
cancer and medical history of cancer hereof (except basal cell skin cancer and squamous cell skin cancer)
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial